Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with type 2 diabetes~* Self-injection naïve to all injectable treatment (for example, diabetes therapies and other medical conditions)~* Injection naïve to performing all injectable treatment (for example, diabetes therapies and other medical conditions) to others~Exclusion Criteria:~* Currently diagnosed with gestational diabetes and/or type 1 diabetes~* Cognitive or physical difficulties that could interfere with ability to understand the training, perform the injection tasks, or complete the study questionnaires as judged by the investigator~* Is a health care practitioner who is trained in giving injections

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dulaglutide Pen (Type: EXPERIMENTAL): Injection of commercial dulaglutide pen on a practice pad.
- Semaglutide Pen (Type: EXPERIMENTAL): Injection of commercial semaglutide pen on a practice pad.

Based on this trial design, predict the completion outcome and termination type (if applicable).